202 related articles for article (PubMed ID: 10588458)
21. Thrombophilia in sickle cell disease: the red cell connection.
Setty BN; Rao AK; Stuart MJ
Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
[TBL] [Abstract][Full Text] [Related]
22. Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers.
Tanaka M; Suzuki A
Thromb Res; 1994 Nov; 76(3):289-98. PubMed ID: 7863479
[TBL] [Abstract][Full Text] [Related]
23. Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation.
Shinohara H; Fukuda N; Soeki T; Takeichi N; Yui Y; Tamura Y; Oki T
Jpn Heart J; 1998 Nov; 39(6):721-30. PubMed ID: 10089934
[TBL] [Abstract][Full Text] [Related]
24. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
[No Abstract] [Full Text] [Related]
25. A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with hunt-hess grade and outcome.
Nina P; Schisano G; Chiappetta F; Luisa Papa M; Maddaloni E; Brunori A; Capasso F; Corpetti MG; Demurtas F
Surg Neurol; 2001 Apr; 55(4):197-203. PubMed ID: 11358585
[TBL] [Abstract][Full Text] [Related]
26. Coagulation and fibrinolysis markers in seminal plasma of patients under evaluation for involuntary childlessness.
van Wersch JW; De Vries-Hanje JC; Ubachs JM
Eur J Clin Chem Clin Biochem; 1992 Aug; 30(8):467-71. PubMed ID: 1445960
[TBL] [Abstract][Full Text] [Related]
27. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
28. Activation of thrombosis and fibrinolysis following brain infarction.
Kataoka S; Hirose G; Hori A; Shirakawa T; Saigan T
J Neurol Sci; 2000 Dec; 181(1-2):82-8. PubMed ID: 11099716
[TBL] [Abstract][Full Text] [Related]
29. D-dimers predict stroke subtype when assessed early.
Isenegger J; Meier N; Lämmle B; Alberio L; Fischer U; Nedeltchev K; Gralla J; Kohler HP; Mattle HP; Arnold M
Cerebrovasc Dis; 2010; 29(1):82-6. PubMed ID: 19907168
[TBL] [Abstract][Full Text] [Related]
30. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
[TBL] [Abstract][Full Text] [Related]
31. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
32. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
[TBL] [Abstract][Full Text] [Related]
33. Markers of a hypercoagulable state following acute ischemic stroke.
Takano K; Yamaguchi T; Uchida K
Stroke; 1992 Feb; 23(2):194-8. PubMed ID: 1561647
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
Kario K; Matsuo T; Kodama K; Matsuo M
Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
[TBL] [Abstract][Full Text] [Related]
35. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
[TBL] [Abstract][Full Text] [Related]
36. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
37. Study of cardiovascular risk factors and hemostatic molecular markers in elderly persons.
Deguchi K; Deguchi A; Wada H; Murashima S
Semin Thromb Hemost; 2000; 26(1):23-7. PubMed ID: 10805277
[TBL] [Abstract][Full Text] [Related]
38. Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers.
Sturzenegger M; Beer JH; Rihs F
Stroke; 1995 Jan; 26(1):63-9. PubMed ID: 7839399
[TBL] [Abstract][Full Text] [Related]
39. Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.
Bots ML; Breteler MM; van Kooten F; Haverkate F; Meijer P; Koudstaal PJ; Grobbee DE; Kluft C
Haemostasis; 1998; 28(3-4):216-22. PubMed ID: 10420069
[TBL] [Abstract][Full Text] [Related]
40. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy.
Rahr HB; Sørensen JV; Larsen JF; Jensen FS; Bredahl C
Scand J Gastroenterol; 1994 Jun; 29(6):516-21. PubMed ID: 8079109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
